本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enlivex Therapeutics Ltd.

0.8066
+0.079410.92%
盤後0.7850-0.0216-2.68%19:30 EDT
成交量:35.01萬
成交額:27.30萬
市值:1,410.38萬
市盈率:0.00
高:0.8190
開:0.7301
低:0.7105
收:0.7272
52周最高:27.15
52周最低:0.6400
股本:1,748.55萬
流通股本:532.27萬
量比:0.89
換手率:6.58%
股息:- -
股息率:- -
每股收益(TTM):382.20
每股收益(LYR):382.20
淨資產收益率:126.17%
總資產收益率:-0.80%
市淨率:0.01
市盈率(LYR):0.00

資料載入中...

2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/01/31

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/23

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/05

SEC問詢函

[Cover]Correspondence
2019/06/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/26

超過5%披露

Statement of acquisition of beneficial ownership by individuals